Folate receptor-β in activated macrophages: Ligand binding and receptor recycling kinetics

Molecular Pharmaceutics

Volumn 11, Issue 10, 2014, Pages 3609-3616

  Varghese, Bindu ^a   Vlashi, Erina ^a   Xia, Wei ^a   Ayala Lopez, Wilfredo ^a   Paulos, Chrystal M ^a   Reddy, Joseph ^b   Xu, Le Cun ^b   Low, Philip S ^a  

^a PURDUE UNIVERSITY   (United States)

^b Endocyte Inc   (United States)

Author keywords

arthritis; endocytosis; folate; internalization; receptor recycling

Indexed keywords

FOLATE RECEPTOR 2; FOLIC ACID DERIVATIVE; PENTETATE INDIUM IN 111; PENTETATE INDIUM IN 111 FOLIC ACID CONJUGATE; UNCLASSIFIED DRUG; FOLIC ACID;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING KINETICS; CELL SURFACE; DRUG DOSE ESCALATION; DRUG RECEPTOR BINDING; HALF LIFE TIME; IN VIVO STUDY; INTERNALIZATION; LIGAND BINDING; MACROPHAGE ACTIVATION; MOLECULAR WEIGHT; NONHUMAN; RAT; VASCULARIZATION; ANIMAL; ARTHRITIS; HUMAN; KINETICS; MACROPHAGE; METABOLISM;

ANIMALS; ARTHRITIS; FOLATE RECEPTOR 2; FOLIC ACID; HUMANS; KINETICS; MACROPHAGES; RATS;

EID: 84907972562     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp500348e     Document Type: Article

References (65)

1. Fujiwara, N.; Kobayashi, K. Macrophages in inflammation Curr. Drug Targets Inflammation Allergy 2005, 4 (3) 281-6
2. De Rycke, L.; Baeten, D.; Foell, D.; Kruithof, E.; Veys, E. M.; Roth, J.; De Keyser, F. Differential expression and response to anti-TNFalpha treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis J. Pathol. 2005, 206 (1) 17-27
3. Danks, L.; Sabokbar, A.; Gundle, R.; Athanasou, N. A. Synovial macrophage-osteoclast differentiation in inflammatory arthritis Ann. Rheum. Dis. 2002, 61 (10) 916-21
4. Allison, M. C.; Poulter, L. W. Changes in phenotypically distinct mucosal macrophage populations may be a prerequisite for the development of inflammatory bowel disease Clin. Exp. Immunol. 1991, 85 (3) 504-9
5. Cappello, M.; Keshav, S.; Prince, C.; Jewell, D. P.; Gordon, S. Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation Gut 1992, 33 (9) 1214-9
6. Rugtveit, J.; Brandtzaeg, P.; Halstensen, T. S.; Fausa, O.; Scott, H. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes Gut 1994, 35 (5) 669-74
7. Bobryshev, Y. V. Monocyte recruitment and foam cell formation in atherosclerosis Micron 2006, 37 (3) 208-22
8. Nhan, T. Q.; Liles, W. C.; Schwartz, S. M. Role of caspases in death and survival of the plaque macrophage Arterioscler., Thromb., Vasc. Biol. 2005, 25 (5) 895-903
9. Tabas, I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency Arterioscler., Thromb., Vasc. Biol. 2005, 25 (11) 2255-64
10. Lenda, D. M.; Kikawada, E.; Stanley, E. R.; Kelley, V. R. Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation J. Immunol. 2003, 170 (6) 3254-62
11. Ren, Y.; Tang, J.; Mok, M. Y.; Chan, A. W.; Wu, A.; Lau, C. S. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus Arthritis Rheum. 2003, 48 (10) 2888-97
12. Tesch, G. H.; Schwarting, A.; Kinoshita, K.; Lan, H. Y.; Rollins, B. J.; Kelley, V. R. Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis J. Clin. Invest. 1999, 103 (1) 73-80
13. Tesch, G. H.; Maifert, S.; Schwarting, A.; Rollins, B. J.; Kelley, V. R. Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice J. Exp. Med. 1999, 190 (12) 1813-24
14. Kang, K.; Reilly, S. M.; Karabacak, V.; Gangl, M. R.; Fitzgerald, K.; Hatano, B.; Lee, C. H. Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity Cell Metab. 2008, 7 (6) 485-95
15. Rawji, K. S.; Yong, V. W. The benefits and detriments of macrophages/microglia in models of multiple sclerosis Clin. Dev. Immunol. 2013, 948976 (10) 12
16. Rowshani, A. T.; Vereyken, E. J. The role of macrophage lineage cells in kidney graft rejection and survival Transplantation 2012, 94 (4) 309-18
17. Nakashima-Matsushita, N.; Homma, T.; Yu, S.; Matsuda, T.; Sunahara, N.; Nakamura, T.; Tsukano, M.; Ratnam, M.; Matsuyama, T. Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis Arthritis Rheum. 1999, 42 (8) 1609-16
18. Turk, M. J.; Breur, G. J.; Widmer, W. R.; Paulos, C. M.; Xu, L. C.; Grote, L. A.; Low, P. S. Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis Arthritis Rheum. 2002, 46 (7) 1947-55
19. Nagayoshi, R.; Nakamura, M.; Ijiri, K.; Yoshida, H.; Komiya, S.; Matsuyama, T. LY309887, antifolate via the folate receptor suppresses murine type II collagen-induced arthritis Clin. Exp. Rheumatol. 2003, 21 (6) 719-25
20. Ross, J. F.; Wang, H.; Behm, F. G.; Mathew, P.; Wu, M.; Booth, R.; Ratnam, M. Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia Cancer 1999, 85 (2) 348-57
21. Puig-Kroger, A.; Sierra-Filardi, E.; Dominguez-Soto, A.; Samaniego, R.; Corcuera, M. T.; Gomez-Aguado, F.; Ratnam, M.; Sanchez-Mateos, P.; Corbi, A. L. Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages Cancer Res. 2009, 69 (24) 9395-403
22. Sierra-Filardi, E.; Puig-Kroger, A.; Blanco, F. J.; Nieto, C.; Bragado, R.; Palomero, M. I.; Bernabeu, C.; Vega, M. A.; Corbi, A. L. Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers Blood 2011, 117 (19) 5092-101
23. Xiaobin Zhao, H. L.; Robert, J Lee. Targeted drug delivery via folate receptors Expert Opin. Drug Delivery 2008, 5 (3) 309-319
24. Elnakat, H.; Ratnam, M. Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy Adv. Drug Delivery Rev. 2004, 56 (8) 1067-84
25. Ross, J. F.; Chaudhuri, P. K.; Ratnam, M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications Cancer 1994, 73 (9) 2432-43
26. Corona, G.; Giannini, F.; Fabris, M.; Toffoli, G.; Boiocchi, M. Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells Int. J. Cancer 1998, 75 (1) 125-33
27. Lu, Y.; Low, P. S. Folate-mediated delivery of macromolecular anticancer therapeutic agents Adv. Drug Delivery Rev. 2002, 54 (5) 675-93
28. Parker, N.; Turk, M. J.; Westrick, E.; Lewis, J. D.; Low, P. S.; Leamon, C. P. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay Anal. Biochem. 2005, 338 (2) 284-93
29. Rochman, H.; Selhub, J.; Karrison, T. Folate binding protein and the estrogen receptor in breast cancer Cancer Detect. Prev. 1985, 8 (1-2) 71-5
30. Franklin, W. A.; Waintrub, M.; Edwards, D.; Christensen, K.; Prendegrast, P.; Woods, J.; Bunn, P. A.; Kolhouse, J. F. New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma Int. J. Cancer, Suppl. 1994, 8, 89-95
31. Holm, J.; Hansen, S. I.; Hoier-Madsen, M.; Sondergaard, K.; Bzorek, M. The high-affinity folate receptor of normal and malignant human colonic mucosa Apmis 1994, 102 (11) 828-36
32. Wang, S.; Low, P. S. Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells J. Controlled Release 1998, 53 (1-3) 39-48
33. Feng, Y.; Shen, J.; Streaker, E. D.; Lockwood, M.; Zhu, Z.; Low, P. S.; Dimitrov, D. S. A folate receptor beta-specific human monoclonal antibody recognizes activated macrophage of rheumatoid patients and mediates antibody-dependent cell-mediated cytotoxicity. Arthritis Res. Ther. 2011, 13, (2).
34. Paulos, C. M.; Varghese, B.; Widmer, W. R.; Breur, G. J.; Vlashi, E.; Low, P. S. Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis Arthritis Res. Ther. 2006, 8 (3) R77
35. Turk, M. J.; Waters, D. J.; Low, P. S. Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma Cancer Lett. 2004, 213 (2) 165-72
36. Paulos, C. M.; Turk, M. J.; Breur, G. J.; Low, P. S. Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis Adv. Drug Delivery Rev. 2004, 56 (8) 1205-17
37. Xia, W.; Hilgenbrink, A. R.; Matteson, E. L.; Lockwood, M. B.; Cheng, J.-X.; Low, P. S. A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages Blood 2009, 113 (2) 438-446
38. Ayala-Lopez, W.; Xia, W.; Varghese, B.; Low, P. S. Imaging of atherosclerosis in apoliprotein e knockout mice: targeting of a folate-conjugated radiopharmaceutical to activated macrophages J. Nucl. Med. 2010, 51, 768-74
39. Furusho, Y.; Miyata, M.; Matsuyama, T.; Nagai, T.; Li, H.; Akasaki, Y.; Hamada, N.; Miyauchi, T.; Ikeda, Y.; Shirasawa, T.; Ide, K.; Tei, C. Novel Therapy for Atherosclerosis Using Recombinant Immunotoxin Against Folate Receptor β-Expressing Macrophages J. Am. Heart Assoc. 2012, 1, e003079
40. Muller, C. Folate based radiopharmaceuticals for imaging and therapy of cancer and inflammation Curr. Pharm. Des. 2012, 18, 1058-1083
41. Paulos, C. M.; Reddy, J. A.; Leamon, C. P.; Turk, M. J.; Low, P. S. Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery Mol. Pharmacol. 2004, 66 (6) 1406-14
42. Bandara, N. A.; Hansen, M. J.; Low, P. S. Effect of Receptor Occupancy on Folate Receptor Internalization. Mol. Pharm. 2014.
43. Antohe, F.; Radulescu, L.; Puchianu, E.; Kennedy, M.; Low, P.; Simionescu, M. Increased uptake of folate conjugates by activated macrophages in experimental hyperlipemia Cell Tissue Res. 2005, 320 (2) 277-285
44. Fletcher, D. S.; Widmer, W. R.; Luell, S.; Christen, A.; Orevillo, C.; Shah, S.; Visco, D. Therapeutic administration of a selective inhibitor of nitric oxide synthase does not ameliorate the chronic inflammation and tissue damage associated with adjuvant-induced arthritis in rats J. Pharm. Exp. Ther. 1998, 284, 714-721
45. He, W.; Wang, H.; Hartmann, L. C.; Cheng, J.-X.; Low, P. S. In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (28) 11760-11765
46. Mathias, C. J.; Green, M. A. A kit formulation for preparation of [(111)In]In-DTPA-folate, a folate-receptor-targeted radiopharmaceutical Nucl. Med. Biol. 1998, 25 (6) 585-7
47. Kamen, B. A.; Smith, A. K. A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro Adv. Drug Delivery Rev. 2004, 56 (8) 1085-97
48. Lu, Y.; Wollak, K. N.; Cross, V. A.; Westrick, E.; Wheeler, L. W.; Stinnette, T. W.; Vaughn, J. F.; Hahn, S. J.; Xu, L. C.; Vlahov, I. R.; Leamon, C. P. Folate receptor-targeted aminopterin therapy is highly effective and specific in experimental models of autoimmune uveitis and autoimmune encephalomyelitis Clin. Immunol. 2014, 150 (1) 64-77
49. Salgado, C.; Vilson, F.; Miller, N. R.; Bernstein, S. L. Cellular inflammation in nonarteritic anterior ischemic optic neuropathy and its primate model Arch. Ophthalmol. (Chicago, IL, U.S.) 2011, 129 (12) 1583-91
50. Zhang, C.; Tso, M. O. Characterization of activated retinal microglia following optic axotomy J. Neurosci. Res. 2003, 73 (6) 840-5
51. Damoiseaux, J. G.; Dopp, E. A.; Calame, W.; Chao, D.; MacPherson, G. G.; Dijkstra, C. D. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1 Immunology 1994, 83 (1) 140-7
52. Yang, J. J.; Kularatne, S. A.; Chen, X.; Low, P. S.; Wang, E. Characterization of in vivo disulfide-reduction mediated drug release in mouse kidneys Mol. Pharmaceutics 2012, 9 (2) 310-7
53. Piscaer, T. M.; Muller, C.; Mindt, T. L.; Lubberts, E.; Verhaar, J. A.; Krenning, E. P.; Schibli, R.; De Jong, M.; Weinans, H. Imaging of activated macrophages in experimental osteoarthritis using folate-targeted animal single-photon-emission computed tomography/computed tomography Arthritis Rheum. 2011, 63 (7) 1898-907
54. Elnakat, H.; Ratnam, M. Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy Adv. Drug Delivery Rev. 2004, 56 (8) 1067-1084
55. Paulos, C. M.; Varghese, B.; Widmer, W. R.; Breur, G. J.; Vlashi, E.; Low, P. S. Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis Arthritis Res. Ther. 2006, 8 (3) 28
56. Leamon, C. P.; Cooper, S. R.; Hardee, G. E. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo Bioconjug. Chem. 2003, 14 (4) 738-47
57. Reddy, J. A.; Westrick, E.; Vlahov, I.; Howard, S. J.; Santhapuram, H. K.; Leamon, C. P. Folate receptor specific anti-tumor activity of folate-mitomycin conjugates Cancer Chemother. Pharmacol. 2005, 1-8
58. Leamon, C. P.; Reddy, J. A.; Vlahov, I. R.; Vetzel, M.; Parker, N.; Nicoson, J. S.; Xu, L. C.; Westrick, E. Synthesis and biological evaluation of EC72: a new folate-targeted chemotherapeutic Bioconjug. Chem. 2005, 16 (4) 803-11
59. Stephenson, S. M.; Low, P. S.; Lee, R. J. Folate receptor-mediated targeting of liposomal drugs to cancer cells Methods Enzymol. 2004, 387, 33-50
60. Lu, Y.; Low, P. S. Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors Cancer Immunol. Immunother. 2002, 51 (3) 153-62
61. Lee, J. W.; Lu, J. Y.; Low, P. S.; Fuchs, P. L. Synthesis and evaluation of taxol-folic acid conjugates as targeted antineoplastics Bioorg. Med. Chem. 2002, 10 (7) 2397-414
62. Hofland, H. E.; Masson, C.; Iginla, S.; Osetinsky, I.; Reddy, J. A.; Leamon, C. P.; Scherman, D.; Bessodes, M.; Wils, P. Folate-targeted gene transfer in vivo Mol. Ther. 2002, 5 (6) 739-44
63. Lu, J. Y.; Lowe, D. A.; Kennedy, M. D.; Low, P. S. Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug J. Drug Targeting 1999, 7 (1) 43-53
64. Leamon, C. P.; Pastan, I.; Low, P. S. Cytotoxicity of folate-Pseudomonas exotoxin conjugates toward tumor cells. Contribution of translocation domain J. Biol. Chem. 1993, 268 (33) 24847-54
65. Leamon, C. P.; Low, P. S. Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis Proc. Natl. Acad. Sci. U.S.A. 1991, 88 (13) 5572-6